A toxic version of a certain protein may affect brain, spinal cord and skeletal muscle tissues differently, leading to the ...

NUZ is advancing its lead drug monepantel, now known as NUZ-001, for the treatment of neurodegenerative diseases, starting ...

HUNTINGTON Jacob Harper, a 23-year-old fighting a rare form of ALS (amyotrophic lateral sclerosis), has become a beacon of hope for many. Diagnosed in 2022 and the youngest person in the state of West ...

Oditrasertib, which blocks the inflammatory RIPK1 protein, earlier this year also failed a Phase II trial in amyotrophic ...

NeuroSense plans to apply to Canada’s regulators for early marketing approval of the oral therapy, supported by a Phase 2b ...

Hall, founder of Beacon of Hope for ALS, aims to lift people up and help them after their diagnosis. Amyotrophic lateral ...

Folks came together at Columbia Point Park in Richland Saturday to help raise money and awareness aboutAmyotrophic lateral ...

Researchers at the Francis Crick Institute and the UCL Queen Square Institute of Neurology have developed DNA molecules which contain "invisibility cloak" sequences, preventing healthy cells from ...

Sanofi's (SNY) experimental therapy DNL788, developed with Denali Therapeutics (SNLI), fails in second mid-stage trial within ...

True to its history of reinvention and repurposing, Pharmaust will be renamed Neurizon Therapeutics after shareholders ...

Billings is a world history and social science teacher on the Elk Grove Unified School District campus and has coached the varsity program for three seasons. He announced early this season that he was ...